Urology of Indiana has announced the launch of a new outpatient Interventional Radiology Center in the US, designed to provide new treatment for benign prostatic hyperplasia (BPH), commonly known as an enlarged prostate.

This facility is set to serve patients in Indianapolis and the surrounding areas with advanced care options.

Urology of Indiana president Dr Ronald Suh said: “Urology of Indiana’s mission is to provide the highest quality, comprehensive urologic care to our patients and referring physicians.

“The integration of Interventional Radiology services into our practice allows patients to receive streamlined management of their condition from the team of providers they know and trust in a convenient, modern outpatient environment.”

The centre is a part of Urology of Indiana, affiliated with US Urology Partners, and backed by NMS Capital.

With over 130 years of history, Urology of Indiana operates through 14 locations, including Center of Excellence and two Integrated Cancer Centers.

The new initiative comprises a partnership with Prostate Centers USA and aims to offer the most advanced treatment options for men with BPH.

The services at the new centre will include prostatic artery embolisation (PAE), a procedure recently endorsed in the 2023 American Urological Guidelines for BPH management.

PAE is said to be a non-surgical alternative that provides long-term relief for BPH with minimal downtime and fewer complications compared to traditional treatments.

Urology of Indiana chief operating officer Shawn Severns said: “Our collaboration with Prostate Centers USA enables Urology of Indiana to bring immediate, nationally recognised expertise in this exciting, new minimally invasive treatment for BPH that safely and effectively treats enlarged prostate glands without surgical intervention.

“We are thrilled to add this specialty and new Interventional Radiology Center to the Urology of Indiana team of highly skilled urologists, urogynaecologists and radiation oncologists.”